MCK — McKesson Corporation

McKesson Corporation (MCK) is a medical distribution company listed on NYSE. It is led by Michele Lau J.D., based in 6555 State Highway 161, Irving, TX, United States, 75039, with about 41,600 employees. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 31.4% from 2025-12-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.

Use this MCK page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MCK quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MCK SEC filings page. Lician reads the product cache first so this HTML stays unique to McKesson Corporation even when a live quote feed is slow.